| 0 |
Dopamine-2 Receptor Antagonist [EPC] |
6 |
0.0008 |
| 1 |
Alkylating Drug [EPC] |
21 |
0.0001 |
| 2 |
Nitrofuran Antibacterial [EPC] |
1 |
0.0001 |
| 3 |
Vitamin D Analog [EPC] |
1 |
0.0001 |
| 4 |
Purine Antimetabolite [EPC] |
5 |
0.0001 |
| 5 |
Antirheumatic Agent [EPC] |
5 |
0.0000 |
| 6 |
Serotonin Reuptake Inhibitor [EPC] |
4 |
0.0000 |
| 7 |
Leukocyte Growth Factor [EPC] |
6 |
0.0000 |
| 8 |
Topoisomerase Inhibitor [EPC] |
3 |
0.0000 |
| 9 |
Folate Analog Metabolic Inhibitor [EPC] |
14 |
0.0000 |
| 10 |
CD20-directed Cytolytic Antibody [EPC] |
9 |
0.0000 |
| 11 |
Interleukin-17A Antagonist [EPC] |
1 |
0.0000 |
| 12 |
Aromatase Inhibitor [EPC] |
3 |
0.0000 |
| 13 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
3 |
0.0000 |
| 14 |
Aminosalicylate [EPC] |
2 |
0.0000 |
| 15 |
Microtubule Inhibitor [EPC] |
3 |
0.0000 |
| 16 |
Corticosteroid [EPC] |
22 |
0.0000 |
| 17 |
Tumor Necrosis Factor Blocker [EPC] |
17 |
0.0000 |
| 18 |
Nitroimidazole Antimicrobial [EPC] |
1 |
0.0000 |
| 19 |
Platinum-based Drug [EPC] |
4 |
0.0000 |
| 20 |
Nucleoside Metabolic Inhibitor [EPC] |
4 |
0.0000 |
| 21 |
Tetracycline-class Drug [EPC] |
1 |
0.0000 |
| 22 |
beta-Adrenergic Blocker [EPC] |
4 |
0.0000 |
| 23 |
Atypical Antipsychotic [EPC] |
5 |
0.0000 |
| 24 |
Parathyroid Hormone Analog [EPC] |
1 |
0.0000 |
| 25 |
Fluoroquinolone Antibacterial [EPC] |
1 |
0.0000 |
| 26 |
Osmotic Laxative [EPC] |
2 |
0.0000 |
| 27 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 28 |
Xanthine Oxidase Inhibitor [EPC] |
1 |
0.0000 |
| 29 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 30 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 31 |
Opioid Agonist [EPC] |
1 |
0.0000 |
| 32 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 33 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 34 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
2 |
0.0000 |
| 35 |
Benzodiazepine [EPC] |
1 |
0.0000 |